Editor, leitor
374
edições
Alterações
→Referências:
14. Strauss O. et al. The role of bestrophin-1 in intracellular Ca(2+) signaling. Advances in experimental medicine and biology. 2014; 801:113–119.
15. Mullins et al. 2007. Differential Macular and Peripheral Expression of Bestrophin in Human Eyes and Its Implication for Best Disease. IOVS, July 2007, Vol. 48, No. 7
16. Woo D.H. et al. TREK-1 and Best1 channels mediate fast and slow glutamate release in astrocytes upon GPCR activation. Cell. 2012; 151:25–40. 17. Park H. et al. Bestrophin-1 encodes for the Ca2+-activated anion channel in hippocampal astrocytes. The Journal of neuroscience: the official journal of the Society for Neuroscience. 2009; 29:13063–13073
https://www.omim.org/entry/607335?search=best2&highlight=best2
18. Yu K. et al. Bestrophin-2 mediates bicarbonate transport by goblet cells in mouse colon. The Journal of clinical investigation. 2010; 120:1722–1735. 19. Cui C.Y. et al. Forkhead transcription factor FoxA1 regulates sweat secretion through Bestrophin 2 anion channel and Na-K-Cl cotransporter 1. Proceedings of the National Academy of Sciences of the United States of America. 2012; 109:1199–1203. 20. Bakall B. et al. Bestrophin-2 is involved in the generation of intraocular pressure. Investigative ophthalmology & visual science. 2008; 49:1563–1570. 21. https://www.omim.org/entry/607337?search=best3&highlight=best3 22. Stohr H. et al. Three novel human VMD2-like genes are members of the evolutionary highly conserved RFP-TM family. Eur J Hum Genet 2002;10: 281–284 23. Matchkov VV et al. Bestrophin-3 (vitelliform macular dystrophy 2-like 3 protein) is essential for the cGMP-dependent calcium-activated chloride conductance in vascular smooth muscle cells. Circ. Res. 103: 864-872, 2008. 24. Lee W.K. et al.. ERK1/2-dependent bestrophin-3 expression prevents ER-stress-induced cell death in renal epithelial cells by reducing CHOP. Biochimica et biophysica acta. 2012; 1823:1864–1876 25. Svenningsen P. Stressed podocytes - Bestrophin-3 is not just Bestrophin-3. Acta physiologica. 2015; 214:430–431. 26. Golubinskaya, V. et al. 2015. Bestrophin‐3 is differently expressed in normal and injured mouse glomerular podocytes. Acta Physiol (Oxf) doi:10.1111/apha.12516. 27. https://www.omim.org/entry/607336?search=best4&highlight=best4 28. Tsunenari T. et al. 2006. Ca(2+)-activated Cl(-) current from human bestrophin-4 in excised membrane patches. J. Gen. Physiol. 127: 749-754, 2006.] 29. Xiao Q., Hartzell H.C.,Yu K. Bestrophins and retinopathies. Pflugers Archiv: European journal of physiology. 2010; 460:559–569. 30. Yu K et al. The Best Disease-Linked Cl Channel hBest1 Regulates Cav1 (Ltype) Ca2+ Channels Via SH3-binding Domains J Neurosci. 2008 May 28; 28(22): 5660–5670. doi:10.1523/JNEUROSCI.0065-08.2008. 31. Singh R et al. iPS cell modeling of Best disease: insights into the pathophysiology of an inherited macular degeneration. Hum Mol Genet. 2013a; 23:593–607. 32. Schachat A.P., Wilisoson CP., Hinton DR., Sadda SR., Wiedemann P. Ryan’s Retina 6th edition, Elsevier (2018). 33. Chowers I. et al. Adult-onset foveomacular vitelliform dystrophy: A fresh perspective. Prog Retin Eye Res. 2015 Jul;47:64-85. doi: 10.1016/j.preteyeres.2015.02.001 34. https://eyewiki.aao.org/Best_Disease 35. https://eyewiki.aao.org/Pattern_dystrophies 36. Crowley C, Paterson R, Lamey T, McLaren T, De Roach J, Chelva E, Khan J. Autosomal recessive bestrophinopathy associated with angle-closure glaucoma. Doc Ophthalmol. 2014 Aug;129(1):57-63. 37. Reddy, M.A. et al. 2003 .A clinical and molecular genetic study of a rare dominantly inherited syndrome (MRCS) comprising of microcornea, rod-cone dystrophy, cataract, and posterior staphyloma. Br. J. Ophthalmol. 87, 197–202. 38. Davidson A.E. et al. Missense mutations in a retinal pigment epithelium protein, bestrophin-1, cause retinitis pigmentosa. American journal of human genetics. 2009; 85:581–592. 39. Zhang Y. et al. Enhanced inflow and outflow rates despite lower IOP in bestrophin-2-deficient mice. Investigative ophthalmology & visual science. 2009; 50:765–770. 40. Hafler BP. Clinical Progress in Inherited Retinal Degenerations: Gene Therapy Clinical Trials and Advances in Genetic Sequencing. Retina. 2017;37(3):417–423. 41. Singh R. et al. Pharmacological Modulation of Photoreceptor Outer Segment Degradation in a Human iPS Cell Model of Inherited Macular Degeneration. Molecular therapy: the journal of the American Society of Gene Therapy. 2015 23:1700–1711. 42. https://eyewiki.aao.org/Voretigene_neparvovec-rzyl_(Luxturna%E2%84%A2) 43. Hafler BP. Clinical Progress in Inherited Retinal Degenerations: Gene Therapy Clinical Trials and Advances in Genetic Sequencing. Retina. 2017;37(3):417–423. 44. Guziewicz KE et al. Recombinant AAV-mediated BEST1 transfer to the retinal pigment epithelium: analysis of serotype-dependent retinal effects. PloS one. 2013; 8:e75666. 45. Guziewicz KE et al. BEST1 gene therapy corrects a diffuse retina-wide microdetachment modulated by light exposure. PNAS March 20, 2018 115 (12) E2839-W2848.